- Home
- GASS vs ACIU Comparison
GASS vs ACIU Comparison
Compare GASS & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GASS
- ACIU
- Stock Information
- Founded
- GASS 2004
- ACIU 2003
- Country
- GASS Greece
- ACIU Switzerland
- Employees
- GASS N/A
- ACIU N/A
- Industry
- GASS Marine Transportation
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- GASS Consumer Discretionary
- ACIU Health Care
- Exchange
- GASS Nasdaq
- ACIU Nasdaq
- Market Cap
- GASS 204.1M
- ACIU 173.7M
- IPO Year
- GASS 2005
- ACIU 2016
- Fundamental
- Price
- GASS $5.37
- ACIU $1.68
- Analyst Decision
- GASS
- ACIU Strong Buy
- Analyst Count
- GASS 0
- ACIU 2
- Target Price
- GASS N/A
- ACIU $10.00
- AVG Volume (30 Days)
- GASS 61.0K
- ACIU 133.4K
- Earning Date
- GASS 05-21-2025
- ACIU 04-30-2025
- Dividend Yield
- GASS N/A
- ACIU N/A
- EPS Growth
- GASS 38.46
- ACIU N/A
- EPS
- GASS 1.90
- ACIU N/A
- Revenue
- GASS $167,262,185.00
- ACIU $32,014,254.00
- Revenue This Year
- GASS N/A
- ACIU N/A
- Revenue Next Year
- GASS $3.49
- ACIU $676.94
- P/E Ratio
- GASS $2.84
- ACIU N/A
- Revenue Growth
- GASS 16.54
- ACIU 91.20
- 52 Week Low
- GASS $4.82
- ACIU $1.43
- 52 Week High
- GASS $8.84
- ACIU $4.98
- Technical
- Relative Strength Index (RSI)
- GASS 49.36
- ACIU 46.75
- Support Level
- GASS $5.30
- ACIU $1.55
- Resistance Level
- GASS $5.57
- ACIU $1.79
- Average True Range (ATR)
- GASS 0.16
- ACIU 0.10
- MACD
- GASS 0.02
- ACIU 0.03
- Stochastic Oscillator
- GASS 68.25
- ACIU 66.67
About GASS StealthGas Inc.
StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.